Abstract:Objective: To investigate the efficacy of CT-guidance interstitial Iodine-125 seed brachytherapy as a salvage therapy for recurrent head and neck carcinoma. Methods: A total of 122 patients who had been treated for recurrent head and neck carcinoma with CT-guided Iodine-125 seed permanent implantation were conducted a retrospective analysis at Peking University Third Hospital from February 2003 to December 2015. The study included 78 male and 44 female patients. Of the 122 patients, 76 had undergone radical surgery, 106 had received EBRT. Among the patients who underwent EBRT, the total dose delivered to PTV ranged from 30 to 140 Gy (median, 68.4 Gy). The actuarial median number of the implanted Iodine-125 seeds was 38 (range, 5-158). The specific activity of Iodine-125 seeds ranged from 14.8 to 28.9 MBq/seed (median, 22.2 MBq). The evaluation of post plan showed the actuarial D90 ranged from 46 to 282 Gy (median, 121 Gy). The overall local control and survival times were determined by using the Kaplan-Meier method from SPSS 13.0.Univariate analysis was performed on the local control rate and overall survival rate. Results: Tumor responses rate was 75.4%. The median local control time was 10.0 months (95% CI 9.8-24.2 months), and the 1-, 2-, 3-, and 5-year local control were 41.9%, 21.2%, 3.7%, and 3.7%, respectively. Univariate analysis showed that the local control in D90≥120 Gy group had an increasing tendency, but no statistical difference were found. The effect of local control in the squamous cell carcinoma group was slightly worse than that in the non-squamous cell carcinoma group (P=0.032). Multi-factor analysis showed that the effect of local control in the squamous cell carcinoma group was slightly poor (P=0.03). The median survival time was 14 months (95% CI 14.4-35.8 months), and the 1-, 2-, 3- and 5-year survival rate were 51.5%, 34.2%, 19.4%, and 19.4%, respectively. The three factors, such as the tumor responses, KPS status before the seed implantation, and the D90 after the seed implantation, had a tendency to improve the total survival, but there was still no statistical differences. Multivariate analysis showed no clear influence factors. Conclusions: Interstitial permanent Iodine-125 seed implantation is an effective salvage re-irradiation modality for recurrent head and neck carcinoma after previous surgery and/or EBRT. CT image-guided method could yield the reliable seeds configuration and accurate dose distribution.

Percutaneous Ultrasonography-Guided Permanent Iodine-125 Implantation As Salvage Therapy for Recurrent Head and Neck Carcimonas

Permanent Implantation of Iodine-125 Seeds As a Salvage Therapy for Recurrent Head and Neck Carcinoma after Radiotherapy

Permanent Implantation of 125I Seeds As a Salvage Therapy for Head and Neck Carcinoma after Radiotherapy

CT-guided Iodine-125 Seed Permanent Implantation for Recurrent Head and Neck Cancers

Percutaneous Permanent Iodine-125 Implantation As Salvage Therapy for Recurrent Salivary Glands Carcinomas

An Investigation of 125 I Seed Permanent Implantation for Recurrent Carcinoma in the Head and Neck after Surgery and External Beam Radiotherapy

Percutaneous Image-Guided Permanent 125 I Implantation for Treating Recurrent Head and Neck Cancer, 2000-2015

[Ct-Guidance Interstitial Iodine-125 Seed Brachytherapy As a Salvage Therapy for Recurrent Head and Neck Carcinoma].

[Ultrasound Guided Implantation of Radioactive (125)I Seeds for Treatment of Recurrent Head and Neck Carcinomas].

Clinical Efficacy of CT-guided Iodine-125 Seed Implantation for Recurrent Head and Neck Carcinoma after External Beam Radiotherapy

5 Year Outcome of Ultrasound-Guided Interstitial Permanent 125i Seeds Implantation for Local Recurrent Tumor of Head and Neck

Five-year outcome of ultrasound-guided interstitial permanent 125 I seeds implantation for local head and neck recurrent tumors: a single center retrospective study.

Effects Of Radioactive Iodine-125 Seed Implantation On Therapeutic Efficacy, Serum Vegf, Cea Levels, And Prognosis Of Patients With Ocular Malignant Tumors

Implantation of Iodine-125 Seed for Head and Neck Carcinoma

Image-Guided Percutaneous 125I Seed Implantation As a Salvage Treatment for Recurrent Soft Tissue Sarcomas after Surgery and Radiotherapy

Long-Term Safety and Efficacy of CT-Guided I125 Radioactive Seed Implantation as a Salvage Therapy for Recurrent Head and Neck Squamous Carcinoma: A Multicenter Retrospective Study

Implantation of 125Ⅰ seeds for recurrence cervical node of head and neck tumor after external beam radiotherapy

Computed Tomography Fluoroscopy-Guided Percutaneous 125I Seed Implantation for Safe, Effective and Real-Time Monitoring Radiotherapy of Inoperable Stage T1-3N0M0 Non-Small-cell Lung Cancer.

[Short- to Mid-Term Evaluation of CT-guided 125I Brachytherapy on Recurrent or Metastatic Head and Neck Cancers].

CT-Guided 125i Seed Implantation for In-Field Recurrence of NSCLC with Prior Radiation

Efficacy of radioactive 125I seed implantation in treating inoperable or refused operation head and neck cancers